AVITA Medical (AVHHL) Liabilities and Shareholders Equity (2018 - 2025)

AVITA Medical has reported Liabilities and Shareholders Equity for 8 years, with the latest figure at $56.4 million in Q4 2025.

• For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 29.25% year-over-year to $56.4 million; the trailing twelve-month figure through Dec 2025 stood at $247.8 million (down 28.37% YoY), and the FY2025 full-year result was $56.4 million, down 29.25% from the prior year.
• Liabilities and Shareholders Equity for Q4 2025 stood at $56.4 million, down from $63.7 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $128.1 million in Q1 2021, with the low at $56.4 million in Q4 2025.
• Historically, Liabilities and Shareholders Equity has averaged $93.2 million across 5 years, with a median of $95.0 million in 2023.
• Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity soared 67.4% — and 2025, when it tumbled 33.81%.
• AVITA Medical's Liabilities and Shareholders Equity stood at $116.0 million in 2021, then retreated by 15.3% to $98.3 million in 2022, then rose by 13.61% to $111.6 million in 2023, then fell by 28.6% to $79.7 million in 2024, then fell by 29.25% to $56.4 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $56.4 million (Q4 2025), $63.7 million (Q3 2025), and $58.1 million (Q2 2025), per Business Quant data.